Japan Lifeline Co., Ltd. (TYO:7575)
Japan · Delayed Price · Currency is JPY 1,263.00
+3.00 (0.24%)
May 14, 2026, 3:30 PM JST
Japan Lifeline Earnings Call Transcripts
Fiscal Year 2026
-
Record sales and profits were achieved, driven by strong core and new product growth, despite margin pressure from inflation and one-time costs. FY 2027 guidance anticipates continued top-line growth but lower profits due to higher investments and relocation expenses.
-
Record H1 sales and profits were driven by strong core and new segment growth, despite headwinds from PFA adoption and price revisions. International expansion and a regenerative medicine partnership marked key developments.
-
Q1 FY2026 delivered 4.3% revenue and 2.4% operating profit growth, with net profit down 1.6% due to FX losses and asset disposals. Strong gains in neurovascular and GI segments offset CRM and PFA-related declines. Progress aligns with full-year guidance.